Product
Tetanus-Diphtheria Toxoid
Aliases
Tetanus-Diphtheria Toxoid (Td)
2 clinical trials
7 indications
Indication
GlioblastomaIndication
Brain CancerIndication
Brain tumorIndication
PrimaryIndication
Brain NeoplasmsIndication
RecurrentIndication
Brain TumorClinical trial
I-ATTAC: Improved Anti-Tumor Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated GliomaStatus: Terminated, Estimated PCD: 2023-02-10
Clinical trial
Patients With IDH1 Positive Recurrent Grade II Glioma Enrolled in a Safety and Immunogenicity Study of Tumor-Specific Peptide VaccineStatus: Completed, Estimated PCD: 2020-02-03